Stock Alert: Milky Mist Dairy Food, LEAP India, E2E Networks, NCC
Shares of LIC Housing Finance and SAIL are banned from F&O trading on 01 September 2026.
New Listings:
Symbiotec Pharmalab will list on the stock exchanges today. The IPO was subscribed 71.26 times. The offer received bids for 93.52 crore shares as against 1.31 crore shares on offer. The issue opened for bidding on 24 August 2026 and closed on 27 August 2026.
Hy-Tech Engineers will list on the stock exchanges today. The IPO was subscribed 244.41 times. The offer received bids for 443.49 crore shares as against 1.84 crore shares on offer. The issue opened for bidding on 24 August 2026 and closed on 27 August 2026.
Skyways Air Services will list on the stock exchanges today. The IPO was subscribed 71.25 times. The offer received bids for 210.79 crore shares as against 2.95 crore shares on offer. The issue opened for bidding on 24 August 2026 and closed on 27 August 2026.
Stocks to Watch:
Auto stocks are expected to stay in focus as automobile companies will release their monthly sales figures.
LEAP India reported a 30.3% YoY increase in consolidated net profit to Rs 24.7 crore in Q1 FY27 from Rs 19 crore in Q1 FY26. Revenue from operations grew 19.1% YoY to Rs 203.4 crore from Rs 170.8 crore.
Milky Mist Dairy Food reported an 889.9% YoY jump in consolidated net profit to Rs 64.7 crore in Q1 FY27 from Rs 6.5 crore in Q1 FY26. Revenue from operations grew 43.6% YoY to Rs 973.4 crore from Rs 678.1 crore.
E2E Networks has entered into a binding term sheet with an India-based Sovereign AI company for the provision of NVIDIA Blackwell cloud GPUs and allied services. The contract is valued at approximately Rs 1,000 crore, excluding applicable taxes, and will remain valid through June 2029.
NCC received three orders worth a total of Rs 430.19 crore in August 2026 for its Buildings Division. The orders were received in the normal course of business.
Brigade Enterprises has announced its entry into Coimbatore with a residential development spread across 5.4 acres in Saravanampatti through a joint development agreement. The project has an estimated gross development value (GDV) of approximately Rs 600 crore.
Cipla has entered into an exclusive licensing and supply agreement with Sino Biopharmaceutical's subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) for Rolditamig Deuderuxtecan, also known as TQB2102, a potential best-in-class HER2 bispecific antibody-drug conjugate (ADC). Under the agreement, Cipla will receive exclusive rights to develop and commercialize TQB2102 in India, South Africa and five other emerging markets. Cipla will handle local clinical development, regulatory activities and commercialization, while CTTQ will manufacture and supply the drug.
Kotak Mahindra Bank has recommended Executive Directors Anup Saha and Paritosh Kashyap to the Reserve Bank of India (RBI) for the position of Managing Director and CEO, according to Reuters. The move is part of the succession process for Ashok Vaswani, whose term ends on December 31, 2026.
Powered by Capital Market - Live News